Lexston Life Sciences Corp. (LEXT.CN)

CAD 0.19

(18.75%)

Revenue Summary of Lexston Life Sciences Corp.

  • Lexston Life Sciences Corp.'s latest annual revenue in 2023 was - CAD , down 0.0% from previous year.
  • Lexston Life Sciences Corp.'s latest quarterly revenue in 2024 Q1 was - CAD , down 0.0% from previous quarter.
  • Lexston Life Sciences Corp. reported a annual revenue of - CAD in annual revenue 2022, down -100.0% from previous year.
  • Lexston Life Sciences Corp. reported a annual revenue of 361.01 Thousand CAD in annual revenue 2021, up 142.11% from previous year.
  • Lexston Life Sciences Corp. reported a quarterly revenue of - CAD for 2023 Q3, down 0.0% from previous quarter.
  • Lexston Life Sciences Corp. reported a quarterly revenue of - CAD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Lexston Life Sciences Corp. (2023 - 2019)

Historical Annual Revenue of Lexston Life Sciences Corp. (2023 - 2019)

Year Revenue Revenue Growth
2023 - CAD 0.0%
2022 - CAD -100.0%
2021 361.01 Thousand CAD 142.11%
2020 149.11 Thousand CAD 0.0%
2019 - CAD 0.0%

Peer Revenue Comparison of Lexston Life Sciences Corp.

Name Revenue Revenue Difference
Algernon Pharmaceuticals Inc. - CAD NaN%
Asep Medical Holdings Inc 21.14 Thousand CAD 100.0%
BetterLife Pharma Inc. - CAD NaN%
BioVaxys Technology Corp. - CAD NaN%
ChitogenX Inc. - CAD NaN%
Rapid Dose Therapeutics Corp. 1.02 Million CAD 100.0%
Defence Therapeutics Inc. - CAD NaN%
Entheon Biomedical Corp. 250.32 Thousand CAD 100.0%
Gemina Laboratories Ltd. - CAD NaN%
Glow Lifetech Corp. 43.93 Thousand CAD 100.0%
Pharmala Biotech Holdings Inc. 532 Thousand CAD 100.0%
Doseology Sciences Inc. 98.52 Thousand CAD 100.0%
MYND Life Sciences Inc. - CAD NaN%
Nova Mentis Life Science Corp. 28.34 Thousand CAD 100.0%
PharmaTher Holdings Ltd. - CAD NaN%
PreveCeutical Medical Inc. - CAD NaN%
Telescope Innovations Corp. 595.39 Thousand CAD 100.0%